Cannabis Compounds Show Potential Against Deadly Fungal Pathogen In Lab Studies
According to a media release by Macquarie University, the compounds also killed dermatophytes that cause common skin infections, and much faster than existing treatments.
The study's findings pave the way for potential new treatments for fungal infections. Published in The Journal of Neglected Tropical Diseases (PLOS NTDs), the research offers promising prospects for addressing these infections.
Fungal infections affect more than one billion people around the world each year, according to data from the Centres for Disease Control and Prevention. Whether it's athlete's foot, a yeast infection, or the potentially deadly lung infection pneumocystis pneumonia, fungal pathogens are a serious health threat with relatively few effective treatments.
Macquarie University's Dr Hue Dinh, a postdoctoral research fellow in the School of Natural Science, and Associate Professor Amy Cain resolved to tackle the growing threat of fungal infections with help from Professor Mark Connor and Dr Marina Junqueira Santiago from the Macquarie School of Medicine and collaborators at the Universities of Sydney and NSW.
Having worked in the field of antimicrobial resistance, Dr Hue Dinh knew that developing an entirely new drug and getting it to market could take decades. It made more sense to work with pharmacological compounds already approved for use in humans for other conditions because their safety and mechanism of action are already well known.
Cannabis connection
Dr Dinh says one of the challenges in the research project was deciding which cannabinoids to test and against what.
"Hundreds of natural compounds can be extracted from the cannabis plant, and we don't know which ones work," says Dr Dinh.
Macquarie Medical School pharmacologist Professor Mark Connor, who has a strong background in researching cannabinoids, joined the team in their quest to target the fungal pathogen Cryptococcus neoformans, which causes deadly lung or brain infections.
"When Cryptococcus neoformans gets to your central nervous system, it causes life-threatening meningitis. The mortality rate is very high, and it's really hard to treat," says Dr Dinh.
The researchers found two cannabinoids - cannabidiol and cannabidivarin - that both quickly killed Cryptococcus neoformans in the laboratory, working even faster than current antifungal therapy.
They tested the compounds against 33 other fungal pathogens from clinical, veterinary and environmental settings. This revealed the cannabinoids were effective in killing a range of Cryptococcus species as well as the fungal skin pathogens that cause athlete's foot.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Hindu
42 minutes ago
- The Hindu
Why pigeon droppings need a public health response and better protection for sanitation staff
In Indian cities, pigeons are a familiar presence -- nesting in the ledges of apartment complexes, roosting above air conditioning units and flocking around public buildings. But while the birds themselves pose no direct harm, doctors are raising concerns over a less visible but significant health issue: the risks from inhaling particles from dried pigeon droppings. Medical experts caution that exposure to these droppings, especially in enclosed or unventilated areas, is linked to serious respiratory and fungal illnesses, particularly among immunocompromised individuals and sanitation workers. Crucially, they are calling for better municipal handling of the issue through a One Health approach as urged by the World Health Organization (WHO) that recognises the interconnectedness of human, animal and environmental well-being. Respiratory damage, fungal and bacterial infections from chronic exposure 'Continuous exposure to pigeon droppings can result in a condition called hypersensitivity pneumonitis, a chronic inflammatory lung disease that may lead to permanent scarring,' explains Aishwarya Rajkumar, senior consultant, pulmonology, Rela Hospital, Chennai. She notes that this is especially dangerous for people with asthma, autoimmune conditions, or those undergoing chemotherapy. Symptoms may begin with a persistent dry cough, tightness in the chest, or breathlessness, which often worsens at night. 'Even a brief exposure, such as cleaning a pigeon-infested space can cause bronchitis-like symptoms, particularly in children with asthma,' she adds. In addition to lung damage, dried droppings may harbour infectious agents. Rajkumar K., senior consultant, pulmonology at MGM Malar, Chennai, warns of cryptococcal infections -- fungal infections that can affect the lungs or brain and chronic hypersensitivity pneumonitis, which can mimic symptoms of tuberculosis or asthma. 'These conditions can present with persistent cough, phlegm, fatigue, and desaturation. Pregnant women, the elderly, and those with heart or respiratory conditions are particularly at risk,' he says. Adding to this, Surendran R., consultant, infectious diseases and hospital infection control, at SIMS Hospital, Chennai, says, 'Cryptococcosis, histoplasmosis, and psittacosis are all illnesses linked to pigeon droppings. In some cases, bacteria such as salmonella and E. coli present in the droppings may cause gastrointestinal infections if contamination occurs.' Who is most at risk? A study published by the Indian Chest Society notes that bird-related hypersensitivity pneumonitis (HP) is common, but confirming exposure remains challenging, highlighting the need for larger multicentre studies. While members of the general public may face a low risk in brief or outdoor contact, experts say the most vulnerable are those who clean affected areas without protection, often workers from marginalised or low-income communities. 'People cleaning attics, terraces, and neglected buildings without gloves or masks are at the highest risk,' says Ranganath R., senior consultant pulmonologist at Narayana Health City, Bengaluru. 'The problem arises when dried droppings turn to dust and get inhaled. This can aggravate asthma or trigger fungal infections.' R. Nanda Kumar, senior consultant in general medicine at SRM Global Hospitals, Chennai, adds, 'Even able-bodied or healthy individuals exposed to large amounts of droppings in closed spaces may develop flu-like symptoms, breathlessness, or in rare cases, neurological signs if the infection spreads.' Call for better healthcare interventions and environmental-specific surveillance What needs urgent attention, experts say, is how cities manage shared spaces where human health intersects with animal activity. Experts highlights that the burden of prevention should not rest solely on individuals. Municipal corporations and resident welfare associations (RWAs) must ensure safer maintenance practices, especially in high-density urban environments. 'Providing protective gear like gloves and masks to cleaning staff must be a basic public health standard,' says Dr. Surendran. 'Cleaning should be done with wet methods to reduce airborne dust, not by sweeping or dry brushing.' Dr. Ranganath recommends installing physical deterrents like nets and conducting regular cleanups in places where pigeons frequently roost. 'We're not urging harm to animals, but only the maintenance of a hygienic environment for both people and birds,' he says. Persistent cough, chest discomfort, unexplained fatigue, wheezing, or fever should prompt medical attention, especially in people with long-term exposure to droppings. 'If a cough lasts more than two weeks and does not improve with standard treatment, we need to rule out infections or hypersensitivity reactions caused by bioaerosols,' says Dr. Rajkumar K. Dr. Nanda Kumar stresses that neurological symptoms, such as headaches, confusion, or visual changes must also be taken seriously in individuals with known exposure. Despite the health risks, India currently lacks formal guidelines or data systems to track illnesses caused by exposure to pigeon droppings. 'Most respiratory infections are tracked broadly, but we don't have environmental-specific surveillance,' says Dr. Nanda Kumar. 'Zoonotic infections from birds are not monitored at the level of tuberculosis or vector-borne diseases.' This, experts say, needs to change. 'Urban planning must account for animal-related health hazards. Public-private partnerships, routine monitoring and awareness drives in semi-urban and rural areas are essential,' says Dr. Rajkumar K.
&w=3840&q=100)
First Post
2 hours ago
- First Post
Hasina's daughter Saima Wazed put on indefinite leave by WHO
Earlier this year, Bangladesh's Anti-Corruption Commission (ACC) accused Hasina's daughter of using her mother's influence to achieve her victory as the regional chief of the WHO read more Advertisement FILE- Bangladesh Prime Minister Sheikh Hasina, centre, is flanked by her daughter Saima Wazed. AP The World Health Organisation has sent Sheikh Hasina's daughter, Saima Wazed, the Southeast Asia chief, on indefinite leave amid Bangladesh's interim government's assertion that she was involved in fraud and corruption during the former prime minister's rule. A report by Health Policy Watch says that the WHO Chief, Dr Tedros Adhanom Ghebreyesus, informed the staff about Wazed's indefinite leave via an email. The leave went into effect from yesterday (June 11). His email added that Dr Catharina Boehme, WHO's assistant director-general, would replace Wazed in taking over the office of the UN health agency's South-East Asia Regional Office (SEARO). STORY CONTINUES BELOW THIS AD What are the allegations against Wazed? Earlier this year, Bangladesh's Anti-Corruption Commission (ACC) accused Hasina's daughter of using her mother's influence to achieve her victory as the regional chief of the WHO. Wazed is also alleged of misrepresenting her academic qualifications during the nomination process, according to ACC Deputy Director Akhtarul Islam. The alleged act falls under Sections 468 and 471 of the Bangladesh Penal Code, which cover forgery and the use of forged documents. She also provided false information regarding her professional experience by claiming an honorary role at Bangabandhu Sheikh Mujib Medical University, which has been categorically denied by the varsity. What else has she been accused of? Wazed has also been accused of widespread corruption during her mother's rule in Bangladesh. The ACC alleges that Wazed exploited her position and influence to secure approximately $2.8 million from multiple banks under the name of the Shuchona Foundation, which she previously headed. Although the exact use of the funds remains uncertain, the charges include Section 420 of the Penal Code for cheating and Section 5(2) of the 1947 Prevention of Corruption Act for abuse of power. Interim govt welcomes move The Muhammad Yunus-led interim government has welcomed the WHO's decision to put Wazed on leave. 'We welcome the World Health Organisation's reported decision to place Saima Wazed on indefinite leave amid ongoing investigations into serious allegations of fraud, forgery and abuse of power. We view this as an important first step toward accountability,' Shafiqul Alam, Yunus' press secretary, said. He added, 'We firmly believe that a permanent resolution is necessary, one that removes Ms. Wazed from her position, revokes all associated privileges and restores integrity to this prestigious role and the credibility of the UN system as a whole.'
Time of India
4 hours ago
- Time of India
WHO unveils roadmap for AI use in traditional medicine
New Delhi: Accepting India's proposal in this regard, the World Health Organisation (WHO) has prepared the first-ever roadmap for use of Artificial Intelligence in traditional medicine. The document titled 'Mapping the application of AI in traditional medicine ' was released on Friday. It mentions several initiatives taken by India to utilise AI and other digital tools for promotion of traditional systems of medicine. These include creation of the Traditional Knowledge Digital Library (TKDL) to digitise text-based formulations of Ayurveda, Unani, Siddha, Sowa Rigpa and practices of Yoga and a project called Ayurgenomics that aims to blend Ayurvedic principles with modern genomics. Ayush secretary Rajesh Kotecha said India had proposed the formation of an AI-in-Traditional-Medicine in the Global Initiative in AI for Health (GI-AI4H), which was accepted by partner nations. "Now, we are actively working with international bodies to set global AI standards for traditional medicine," he said. The WHO technical brief provides a forward-looking roadmap for AI-enabled research, diagnostics and personalised treatment pathways in traditional medicine sector. Kotecha said that based on this roadmap, the ministry of Ayush is developing indigenous AI chatbots to support practitioners and patients, thereby accelerating the modernisation and global reach of traditional medicine. "The Ayush Grid is deploying AI-powered tools - predictive systems and yoga recommendation - for personalised and citizen-centric healthcare," he said. Union minister of state (IC), Ayush ministry, Prataprao Jadhav said the recognition of India's AI-driven initiatives in the WHO's technical brief is a testament to the dedication of the country's scientists to advancing traditional medicine by integrating it with the latest technology. "Through the integration of AI with Ayush systems, India is not only preserving its rich medical heritage but also setting new benchmarks in personalised and evidence-based healthcare for the world," Jadhav said. One of the standout features of the WHO brief is the mention of Ayurgenomics, a scientific breakthrough that combines genomics with Ayurvedic principles. This initiative aims to identify predictive disease markers and personalise health recommendations by using AI-based analysis of Ayurvedic constitution types. The document also highlights efforts to decode the genomic and molecular basis of herbal formulations for repurposing in modern disease conditions-a major leap in integrating traditional wisdom with contemporary science. India's initiatives to digitise traditional knowledge are being praised as global models for the preservation and responsible use of indigenous medical heritage.
